The productive techniques and constitutive effects of ‘evidence-based policy’ and ‘consumer participation’ discourses in health policy processes

Kari Lancaster, Kathryn Leigh Seear, Carla Treloar, Alison Ritter

Research output: Contribution to journalArticleResearchpeer-review

18 Citations (Scopus)

Abstract

For over twenty years there have been calls for greater ‘consumer’ participation in health decision making. While it is recognised by governments and other stakeholders that ‘consumer’ participation is desirable, barriers to meaningful involvement nonetheless remain. It has been suggested that the reifying of ‘evidence-based policy’ may be limiting opportunities for participation, through the way this discourse legitimates particular voices to the exclusion of others. Others have suggested that assumptions underpinning the very notion of the ‘affected community’ or ‘consumers’ as fixed and bounded ‘policy publics’ need to be problematised. In this paper, drawing on interviews (n ¼ 41) with individuals closely involved in Australian drug policy discussions, we critically interrogate the productive techniques and constitutive effects of ‘evidence-based policy’ and ‘consumer participation’ discourses in the context of drug policy processes. To inform our analysis, we draw on and combine a number of critical perspectives including Foucault's concept of subjugated knowledges, the work of feminist theorists, as well as recent work regarding conceptualisations of emergent policy publics. First, we explore how the subject position of ‘consumer’ might be seen as enacted in the material-discursive practices of ‘evidence-based policy’and ‘consumer participation’ in drug policy processes. Secondly, we consider the centralising power effects of the dominant ‘evidence-based policy’ paradigm, and how resistance may be thought about in this context. We suggest that such interrogation has potential to recast the call for ‘consumer’participation in health policy decision-making and drug policy processes.
Original languageEnglish
Pages (from-to)60-68
Number of pages9
JournalSocial Science and Medicine
Volume176
DOIs
Publication statusPublished - 2017

Keywords

  • Australia
  • Consumer participation
  • Drug policy
  • Evidence-based policy
  • Poststructuralism
  • Subjectivity

Cite this

@article{588c07741c354ff09bc67f2dbcfca730,
title = "The productive techniques and constitutive effects of ‘evidence-based policy’ and ‘consumer participation’ discourses in health policy processes",
abstract = "For over twenty years there have been calls for greater ‘consumer’ participation in health decision making. While it is recognised by governments and other stakeholders that ‘consumer’ participation is desirable, barriers to meaningful involvement nonetheless remain. It has been suggested that the reifying of ‘evidence-based policy’ may be limiting opportunities for participation, through the way this discourse legitimates particular voices to the exclusion of others. Others have suggested that assumptions underpinning the very notion of the ‘affected community’ or ‘consumers’ as fixed and bounded ‘policy publics’ need to be problematised. In this paper, drawing on interviews (n ¼ 41) with individuals closely involved in Australian drug policy discussions, we critically interrogate the productive techniques and constitutive effects of ‘evidence-based policy’ and ‘consumer participation’ discourses in the context of drug policy processes. To inform our analysis, we draw on and combine a number of critical perspectives including Foucault's concept of subjugated knowledges, the work of feminist theorists, as well as recent work regarding conceptualisations of emergent policy publics. First, we explore how the subject position of ‘consumer’ might be seen as enacted in the material-discursive practices of ‘evidence-based policy’and ‘consumer participation’ in drug policy processes. Secondly, we consider the centralising power effects of the dominant ‘evidence-based policy’ paradigm, and how resistance may be thought about in this context. We suggest that such interrogation has potential to recast the call for ‘consumer’participation in health policy decision-making and drug policy processes.",
keywords = "Australia, Consumer participation, Drug policy, Evidence-based policy, Poststructuralism, Subjectivity",
author = "Kari Lancaster and Seear, {Kathryn Leigh} and Carla Treloar and Alison Ritter",
year = "2017",
doi = "10.1016/j.socscimed.2017.01.031",
language = "English",
volume = "176",
pages = "60--68",
journal = "Social Science and Medicine",
issn = "0277-9536",
publisher = "Pergamon",

}

The productive techniques and constitutive effects of ‘evidence-based policy’ and ‘consumer participation’ discourses in health policy processes. / Lancaster, Kari; Seear, Kathryn Leigh; Treloar, Carla; Ritter, Alison.

In: Social Science and Medicine, Vol. 176, 2017, p. 60-68.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - The productive techniques and constitutive effects of ‘evidence-based policy’ and ‘consumer participation’ discourses in health policy processes

AU - Lancaster, Kari

AU - Seear, Kathryn Leigh

AU - Treloar, Carla

AU - Ritter, Alison

PY - 2017

Y1 - 2017

N2 - For over twenty years there have been calls for greater ‘consumer’ participation in health decision making. While it is recognised by governments and other stakeholders that ‘consumer’ participation is desirable, barriers to meaningful involvement nonetheless remain. It has been suggested that the reifying of ‘evidence-based policy’ may be limiting opportunities for participation, through the way this discourse legitimates particular voices to the exclusion of others. Others have suggested that assumptions underpinning the very notion of the ‘affected community’ or ‘consumers’ as fixed and bounded ‘policy publics’ need to be problematised. In this paper, drawing on interviews (n ¼ 41) with individuals closely involved in Australian drug policy discussions, we critically interrogate the productive techniques and constitutive effects of ‘evidence-based policy’ and ‘consumer participation’ discourses in the context of drug policy processes. To inform our analysis, we draw on and combine a number of critical perspectives including Foucault's concept of subjugated knowledges, the work of feminist theorists, as well as recent work regarding conceptualisations of emergent policy publics. First, we explore how the subject position of ‘consumer’ might be seen as enacted in the material-discursive practices of ‘evidence-based policy’and ‘consumer participation’ in drug policy processes. Secondly, we consider the centralising power effects of the dominant ‘evidence-based policy’ paradigm, and how resistance may be thought about in this context. We suggest that such interrogation has potential to recast the call for ‘consumer’participation in health policy decision-making and drug policy processes.

AB - For over twenty years there have been calls for greater ‘consumer’ participation in health decision making. While it is recognised by governments and other stakeholders that ‘consumer’ participation is desirable, barriers to meaningful involvement nonetheless remain. It has been suggested that the reifying of ‘evidence-based policy’ may be limiting opportunities for participation, through the way this discourse legitimates particular voices to the exclusion of others. Others have suggested that assumptions underpinning the very notion of the ‘affected community’ or ‘consumers’ as fixed and bounded ‘policy publics’ need to be problematised. In this paper, drawing on interviews (n ¼ 41) with individuals closely involved in Australian drug policy discussions, we critically interrogate the productive techniques and constitutive effects of ‘evidence-based policy’ and ‘consumer participation’ discourses in the context of drug policy processes. To inform our analysis, we draw on and combine a number of critical perspectives including Foucault's concept of subjugated knowledges, the work of feminist theorists, as well as recent work regarding conceptualisations of emergent policy publics. First, we explore how the subject position of ‘consumer’ might be seen as enacted in the material-discursive practices of ‘evidence-based policy’and ‘consumer participation’ in drug policy processes. Secondly, we consider the centralising power effects of the dominant ‘evidence-based policy’ paradigm, and how resistance may be thought about in this context. We suggest that such interrogation has potential to recast the call for ‘consumer’participation in health policy decision-making and drug policy processes.

KW - Australia

KW - Consumer participation

KW - Drug policy

KW - Evidence-based policy

KW - Poststructuralism

KW - Subjectivity

UR - http://www.scopus.com/inward/record.url?scp=85010282466&partnerID=8YFLogxK

U2 - 10.1016/j.socscimed.2017.01.031

DO - 10.1016/j.socscimed.2017.01.031

M3 - Article

VL - 176

SP - 60

EP - 68

JO - Social Science and Medicine

JF - Social Science and Medicine

SN - 0277-9536

ER -